1. B e b elm an M P, Sm it M J, P egtel D M , B aglio SR. B iogenesis an d fu n ctio n o f extracellular v esicles in cancer.
P h arm aco l Ther. 2018; 188:1-11.
2. B e ck e r A, T h ak u r B K , W eiss JM , K im HS, P einado H et al. E xtracellular vesicles in cancer: cell-to-cell m ediators o f m etastasis. C ancer Cell. 2016; 30(6):836-848.
3. S urm an M , S tępień E, H oja-Ł ukow icz D, P rzybyło M . D ecip h erin g th e role o f ectosom es in cancer developm ent an d progression: fo cu s o n the proteom e. C lin E xp M etastasis. 2017 34(3-4):273-289.
4. M aas SLN, B reak efield X O , W eav er AM . E x tracellu lar vesicles: unique intercellular delivery vehicles.
T rends C ell Biol. 2017; 27(3):172-188.
5. v a n N iel G, D 'A ngelo G, R aposo G. S hedding light o n the cell b iology o f extracellular vesicles. N at R e v M ol C ell Biol. 2018; 19(4):213-228.
6. X u R, G reening D W , Z h u H J, T akahashi N , S im pson RJ. E x tracellu lar vesicle iso latio n and characterization:
to w ard clinical application. J C lin Invest. 2016; 126(4): 1152-1162.
7. K o noshenko M Y , L ekchnov E A , V lassov AV , L aktionov PP. Isolation o f ex tracellu lar vesicles: general m ethodologies an d latest trends. B io m ed R es Int. 2018; 2018:8545347.
8. L ucchetti D, F attorossi A, Sgam bato A. E x trac ellu lar v esicles in oncology: progress an d p itfalls in the m ethods o f iso latio n an d analysis. B iotechnol J. 2019; 14(1):e1700716.
9. L iv sh its M A , K hom yakova E, E vtushenko EG , L azarev V N , K ulem in N A et al. Isolation o f exosom es by differential centrifugation: theoretical analysis o f a com m only u se d protocol. Sci Rep. 2015; 5:17319.
10. C vjetkovic A, L ötv all J, L ässer C. T he influence o f ro to r type an d centrifugation tim e o n the y ie ld an d purity o f extracellular vesicles. J E xtracell V esicles. 2014; 3.
11. Iw ai K , Y am am oto S, Y o sh id a M , S hiba K. Iso latio n o f ex tracellu lar v esicles in saliva u sin g density gradient ultracentrifugation. M ethods M o l Biol. 2017; 1660:343-350.
12. O nódi Z, P elyhe C, T erézia N agy C, B ren n er GB, A lm asi L et al. Isolation o f high-purity extracellular v esicles b y the com b in atio n o f iodixanol density g radient ultracen trifu g atio n an d b in d -elu te chrom atography fro m b lo o d plasm a. F ro n t P hysiol. 2018; 9:1479.
13. B ö in g AN , v a n d er P o l E, G rootem aat A E, C oum ans FA, Sturk A et al. Single-step isolation o f extracellular v esicles b y size-exclusion chrom atography. J E xtracell V esicles. 2014; 3.
14. H u n g M E, L enzini SB, S tranford D M , L eo n a rd JN. E nrichm ent o f ex tracellu lar vesicle subpopulations v ia affinity chrom atography. M ethods M o l Biol. 2018; 1740:109-124.
15. X u Y, Q in S, A n T, T an g Y, H u an g Y et al. M iR -145 detection in urinary extracellular vesicles increase diagnostic efficiency o f prostate cancer b ased on hydrostatic filtratio n dialysis m ethod. Prostate. 2017;
77(10):1167-1175.
16. C h en Y , H o n g G, W u F, Sheng J, Z o u Z et al. C om parison o f hydrostatic filtration dialysis w ith ultracen trifu g atio n m ethods fo r the identification an d proteom ic pro filin g o f urinary ex tracellu lar vesicles.
C lin Lab. 2019; 65(4).
17. X u R, R ai A, C hen M , S uw akulsiri W , G reening D W , S im pson RJ. E x trac ellu lar v esicles in can cer - im plications fo r future im provem ents in can cer care. N a t R ev C lin O ncol. 2018; 15(10):617-638.
18. V ad e r P, M o l E A , P asterkam p G, Schiffelers RM . E xtracellu lar v esicles fo r dru g delivery. A dv D rug D eliv
19. S urm an M , D rożdż A, S tępień E, P rzybyło M. E x trac ellu lar v esicles as drug delivery system s - m ethods o f p ro d u ctio n an d p otential th erapeutic applications. C u rr P h arm D es. 2019; 25(2):132-154.
20. D 'S ouza-S chorey C, Schorey JS. R eg u latio n an d m echanism s o f extracellular vesicle b io g e n esis and secretion. E ssays B iochem . 2018; 62(2):125-133.
21. T ricarico C, C lancy J, D 'S ouza-S chorey C. B iology and b iogenesis o f shed m icrovesicles. Sm all G TPases.
2017; 8(4):220-232.
22. H essv ik N P, L lorente A. C urrent know ledge o n exosom e b iogenesis and release. C ell M o l L ife Sci. 2018;
75(2):193-208.
23. H au se r P, W ang S, D idenko VV. A poptotic B odies: Selective D etectio n in E x tracellu lar V esicles. M ethods M o l Biol. 2017; 1554:193-200.
24. W o lf P. T he nature an d significance o f p latelet products in h um an plasm a. B r J H aem atol. 1967;13:269-288.
25. S inauridze EI, K ireev D A , P openko N Y , P ich u g in AV, P anteleev M A et al. P latelet m icroparticle m em branes have 50- to 100-fold h ig h e r specific p ro coagulant activity th a n activated platelets. T hrom b H aem ost. 2007;
97:425-434.
26. V an D e r M eijd en PE, V an S chilfgaarde M , V an O erle R, R enné T, te n Cate H et al. P latelet- and erythrocyte- d eriv ed m icroparticles trig g e r th ro m b in gen eratio n v ia fac to r X IIa. J T hrom b H aem ost. 2012; 10:1355-1362.
27. D istler JH , P isetsky D S, H u b er L C , K ald en JR, Gay S et al. M icroparticles as regulators o f inflam m ation:
n o v el players o f ce llu lar crosstalk in the rheum atic diseases. A rthritis R heum . 2005; 52:3337-3348.
28. K o p p ler B, C ohen C, S ch londorff D, M a ck M . D ifferential m echanism s o f m icroparticle tran sfer to B cells an d m onocytes: anti-inflam m atory p roperties o f m icroparticles. E u r J Im m unol. 2006; 36:648-660.
29. G asser O, S chifferli JA. A ctivated polym o rp h o n u clear neutrophils dissem inate an ti-inflam m atory m icroparticles by ectocytosis. Blood. 2004; 104:2543-2548.
30. Jodo S, X iao S, H o h lb au m A, Strehlow D, M arsh ak -R o th stein A et al. A poptosis-inducing m em brane vesicles. A novel agent w ith unique properties. J B iol Chem . 2001; 276:39938-39944.
31. T im a r CI, L orincz AM , C sépanyi-K ôm i R, V alyi-N agy A, N agy G et al. A ntibacterial effect o f m icrovesicles released fro m h u m a n neutrophilic granulocytes. B lood. 2013; 121:510-518.
32. C andelario K M , S teindler DA. The role o f ex tracellu lar v esicles in the p rogression o f neurodegenerative disease an d cancer. T rends M ol M ed. 2014; 20:368-374.
33. D u jard in S, B ég ard S, C aillierez R, L achaud C, D elattre L et al. Ectosom es: a new m echanism fo r non- ex osom al secretion o f ta u protein. P L oS One. 2014; 9:e100760.
34. Jo sh i P, T urola E, R u iz A, B ergam i A, L ib e ra D D et al. M icroglia convert aggregated am yloid-beta into n eurotoxic fo rm s th ro u g h the shedding o f m icrovesicles. C ell D ea th D iffer. 2014; 21:582-593.
35. G abrielli M , B a ttista N, R iganti L, P ra d a I, A ntonucci F et al. A ctive endocannabinoids are secreted on ex tracellu lar m em brane vesicles. E M B O Rep. 2015; 16(2):213-220.
36. C am ussi G, D eregibus M C , C antaluppi V. R ole o f stem -cell-derived m icrovesicles in the paracrine ac tio n o f stem cells. B io ch em Soc Trans. 2013; 41:283-287.
37. B runo S, C am ussi G. R ole o f m esenchym al stem cell-derived m icrovesicles in tissue repair. P ed ia tr N ephrol.
2013; 28:2249-2254.
38. D w y er R M , P otter-B eirne SM, H arrin g to n K A , L ow ery AJ, H ennessy E et al. M onocyte chem otactic protein- 1 secreted b y prim ary b re a st tum ors stim ulates m ig ra tio n o f m esenchym al stem cells. C lin C an cer R es 2007;
13:5020-5027.
39. Z o u X, Z h an g G, C heng Z, Y in D , D u T et al. M icrovesicles derived from hum an W harton's Jelly m esenchym al strom al cells am eliorate renal isch em ia-rep erfu sio n injury in rats by suppressing CX 3C L1.
S tem C ell R es Ther. 2014; 5:40.
40. D eregibus M C , C antaluppi V, C alogero R, L o Iacono M , T etta C et al. E ndothelial progenitor cell derived m icrovesicles activate an angiogenic p rogram in en dothelial cells b y a horizontal tran sfe r o f m R N A . B lood.
2007; 110:2440-2448.
41. C antaluppi V, G atti S, M edica D, F igliolini F, B runo S e t al. M icrovesicles derived fro m endothelial p ro g en ito r cells p rotect the kidney fro m isch em ia-rep erfu sio n injury b y m ic roR N A -dependent reprogram m ing o f resident renal cells. K idney Int. 2012; 82:412-427.
42. Z h u YG , F en g X M , A b bott J, F an g X H , H ao Q et al. H um an m esenchym al stem cell m icrovesicles for treatm en t o f E sch erich ia coli en dotoxin-induced acute lu n g injury in m ice. S tem Cells. 2014; 32:116-125.
43. F rie n d C, M arovitz W , H enie G, H enie W , T suei D et al. O bservations on cell lines derived from a patient w ith H o d g k in ’s disease. C ancer Res. 1978; 38:2581-2591.
44. R eynés G, V ila V, F leitas T, R e g an o n E, F o n t de M o ra J e t al. Circulating endothelial cells and procoagulant m icroparticles in p atients w ith glioblastom a: prognostic value. P L oS ONE. 2013; 8(7):e69034.
45. F leitas T, M artm ez-S ales V, V ila V, R e g an o n E, M esado D et al. C irculating endothelial cells and m icroparticles as prognostic m arkers in advanced non-sm all cell lu n g cancer. P LoS O N E. 2012;
7(10):e47365.
46. K rish n an SR, L u k F, B ro w n RD , S uen H , K w a n Y et al. Isolation o f hum an C D 138(+) m icroparticles from th e p lasm a o f patients w ith m ultiple m yelom a. N eoplasia. 2016; 18:25-32.
47. M ege D , P anicot-D ubois L, O uaissi M , R o b ert S, S ielezneff I et al. The origin and concentration o f circulating m icroparticles d iffer according to c a n ce r type and evolution: a prospective sin g le-ce n ter study.
In t J Cancer. 2016; 138:939-948.
48. A l-N edaw i K, M e eh a n B, M ic a lle f J, L hotak V, M ay L et al. Intercellular transfer o f the oncogenic receptor E G F R v III b y m icrovesicles d erived fro m tu m o u r cells. N at C ell Biol. 2008; 10:619-624.
49. G inestra A, M o n ea S, S eghezzi G, D olo V, N agase H et al. U rokinase plasm inogen activator and gelatinases are associated w ith m em brane v esicles shed b y h um an H T 1080 fibrosarcom a cells. J B iol Chem . 1997;
272:17216-17222.
50. D olo V, D ’A scenzo S, V iolini S, P om pucci L, F estuccia C et al. M atrix-degrading proteinases are shed in m em brane v esicles b y o v aria n c a n ce r cells in v iv o and in vitro. C lin E xp M etastasis. 1999; 17:131-140.
51. D olo V, G inestra A, C assarr D, V iolini S, L u can ia G et al. Selective localization o f m atrix m etalloproteinase 9, beta1 integrins, an d h um an lym phocyte antigen class I m olecules o n m em brane v esicles shed b y 8701-B C b rea st carcinom a cells. C ancer Res. 1998; 58:4468-4474.
52. C astellana D , Z obairi F, M artinez M C , P anaro M A , M itolo V et al. M em brane m icrovesicles as actors in the e stablishm ent o f a favorable prostatic tum oral niche: a role fo r activated fibroblasts an d C X 3C L 1-C X 3C R 1 axis. C ancer Res. 2009; 69:785-793.
53. A ngelucci A, D ’A scenzo S, F estu ccia C, G ravina GL, B olo g n a M e t al. V esicle-associated urokinase p la sm in o g e n activ ato r prom otes in v a sio n in prostate can cer cell lines. C lin E x p M etast. 2000; 18:163-170.
54. W ysoczynski M , R atajczak M Z. L u n g can cer secreted m icrovesicles: u nderappreciated m odulators o f
m ic roenvironm ent in ex p an d in g tum ors. In t J Cancer. 2009; 125:1595-1603.
55. L o C icero A, M ajkow ska I, N agase H, D i L iegro I, T roeberg L. M icrovesicles shed by oligodendrogliom a cells an d rheum atoid synovial fibroblasts contain aggrecanase activity. M atrix Biol. 2012; 3 1 :229-233.
56. M illim aggi D , M ari M , D ’A scenzo S, C arosa E, Jannini E A et al. T um or vesicle-associated C D 147 m odulates th e angiogenic capability o f endothelial cells. N eoplasia. 2007; 9:349-357.
57. S chroder W A , M ajo r L D , L e TT, G ardner J, Sw eet M J et al. T um or cell-expressed SerpinB2 is present on m icroparticles an d inhibits m etastasis. C ancer M ed. 2014; 3:500-513.
58. T araboletti G, D ’A scenzo S, G iusti I, M archetti D, B orsotti P et al. B ioavailability o f V E G F in tum or-shed v esicles depends o n vesicle b u rst induced by acidic pH . N eoplasia. 2006; 8:96-103.
59. L iu Y, Z h u XJ, Z en g C, W u PH, W ang H X et al. M icrovesicles secreted from h um an m ultiple m yelom a cells p rom ote angiogenesis. A cta P harm acol Sin. 2014; 35:230-238.
60. Y am a d a N , T sujim ura N, K um azak i M , Shinohara H, T aniguchi K et al. C olorectal cancer cell-derived m icrovesicles contain in g m icroR N A -1246 prom ote angiogenesis b y activating S m ad 1/5/8 signaling elicited by P M L d o w n-regulation in en dothelial cells. B io ch im B iophys A cta. 2014; 1839:1256-1272.
61. K im CW , L ee H M , L ee TH , K an g C, K leinm an H K et al. E xtracellular m em brane vesicles from tu m o r cells p rom ote angiogenesis v ia sphingom yelin. C ancer Res. 2002; 62:6312-6317.
62. M u n ster M , F re m d er E, M iller V, B en -T sed ek N, D av id i S et al. A nti-V E G F -A affects the angiogenic p roperties o f tu m or-derived m icroparticles. P L oS O N E. 2014; 9(4):e95983.
63. E su m i N , T odo S, Im ashuku S. P latelet aggregating activity m ed iated by th ro m b in gen eratio n in th e N C G h u m a n n euroblastom a cell line. C ancer R es. 1987; 47:2129-2135.
64. M e zo u a r S, M ege D , D arbousset R, F arge D, D ebourdeau P et a l. Involvem ent o f platelet-derived m icroparticles in tu m o r p ro g re ssio n and throm bosis. S em in O ncol. 2014; 41:346-358.
65. T ru m m er A, D e R o p S, S tadler M , G anser A, B u chholz S. P -se lec tin g lycoprotein ligand-1 positive m icroparticles in allogeneic stem cell tran sp lan tatio n o f hem atologic m alignancies. E x p H em atol. 2011;
39:1047-1055.
66. L im a LG , L eal AC, V argas G, P orto-C arreiro I, M onteiro RQ. In tercellular tran sfe r o f tissue fac to r v ia the u ptake o f tum o r-d eriv ed m icrovesicles. T hrom b Res. 2013; 132:450-456.
67. B aj-K rzyw orzeka M , W eglarczyk K , M y tar B, S zatanek R , B a ra n J et a l. T um our-derived m icrovesicles c o n tain interleukin-8 an d m odulate pro d u ctio n o f chem okines b y h um an m onocytes. A ntican cer Res. 2011;
31:1329-1335.
68. V alenti R , H u b er V, F ilipazzi P, P illa L, S ovena G et a l . H um an tum or-released m icrovesicles prom ote the d ifferentiation o f m y elo id cells w ith transform ing gro w th facto r-b eta-m ed iated suppressive activity o n T lym phocytes. C ancer Res. 2006; 66:9290-9298.
69. K u an g D M , W u Y , C h en N , C heng J, Z h u an g SM et al. T um or-derived hyaluronan induces form ation o f im m unosuppressive m acrophages th ro u g h tran sien t early activation o f m onocytes. Blood. 2007; 110:587
595.
70. B aj-K rzy w o rzek a M , M y tar B, Szatanek R , S urm iak M , W ęglarczyk K et al. C olorectal cancer-derived m icrovesicles m odulate d ifferentiation o f hum an m onocytes to m acrophages. J T ransl M ed. 2016; 14:1-15.
71. L u JF, L u k G, G ong J, Jaisw al R , G rau G E et al. M icroparticles m ediate M R P1 intercellular tran sfer and the re-tem plating o f intrinsic resistance pathw ays. P harm acol Res. 2013; 76:77-83.
72. S hedden K, X ie X T, C handaroy P, C hang Y T, R o san ia GR. E x p u lsio n o f sm all m olecules in v esicles shed by can cer cells: asso ciatio n w ith g ene expression and chem osensitivity profiles. C ancer Res. 2003; 6 3 :4 3 3 1 4337.
73. Jorfi S, A nsa-A ddo EA , K h o lia S, S tratton S, V alley S et al. Inhibition o f m icrovesiculation sensitizes p rostate can cer cells to chem otherapy an d reduces docetaxel dose required to lim it tu m o r g ro w th in vivo. Sci R ep. 2015; 5:1-13.
74. B ray F, F erlay J, S oerjom ataram I, Siegel R L, T orre L A et al. G lobal cancer statistics 2018: G LO B O C A N estim ates o f incidence and m ortality w orldw ide fo r 36 cancers in 185 countries. C A C an cer J Clin. 2018;
68(6):394-424.
75. P oste G, N ico lso n GL. A rrest and m etastasis o f blo o d -b o rn e tu m o r cells are m o dified by fu sio n o f p lasm a m em brane v esicles fro m highly m etastatic cells. P ro c N atl A cad Sci U S A. 1980 77(1):399-403.
76. L im a L G , O liveira AS, C am pos L C , B onam ino M , C ham m as R et al. M alignant transform ation in m elanocytes is associated w ith increased p ro d u ctio n o f p ro co a g u lan t m icrovesicles. T hrom b H aem ost. 2011;
106(4):712-723.
77. H atan ak a M , H igashi Y , F ukushige T, B ab a N , K aw ai K et al. C leaved CD 147 shed from the surface o f m alig n an t m elanom a cells activates M M P 2 pro d u ced b y fibroblasts. A ntican cer Res. 2014; 34(12):7091- 7096.
78. C lancy JW , Sedgw ick A, R osse C, M uralidharan-C hari V, R aposo G et al. R egulated delivery o f m olecular cargo to invasive tu m our-derived m icrovesicles. N a t Com m un. 2015; 6:6919.
79. Z h ao X P, W ang M , Song Y, Song K , Y an TL et al. M em brane m icrovesicles as m ediators fo r m elanom a- fib ro b lasts com m unication: roles o f the V C A M -1/V L A -4 axis an d the E R K 1/2 signal pathw ay. C ancer Lett.
2015; 360(2):125-133.
80. M artinez-L orenzo M J, A nel A, A lav a M A , P i?eiro A, N aval J et al. The hum an m elanom a cell line M elJuSo secretes b ioactive F asL an d A P O 2L /T R A IL o n the surface o f m icrovesicles. P ossible co ntribution to tu m o r counterattack. E xp C ell Res. 2004; 295(2):315-329.
81. M annavola F, T ucci M , F elici C, P assarelli A, D 'O ronzo S et al. T um or-derived exosom es prom ote the in v itro o steotropism o f m elanom a cells by activating th e S D F -1/C X C R 4/C X C R 7 axis. J T ransl M ed. 2019;
17(1):230.
82. H oshino A, C osta-S ilva B, S hen TL, R odrigues G, H ashim oto A et al. T um our exosom e integrins determ ine organotropic m etastasis. N ature. 2015; 527(7578):329-335.
83. X iao D, B arry S, K m etz D, E g g er M , P a n J et al. M elanom a cell-derived exosom es prom ote epithelial
m esenchym al tran sitio n in prim ary m elanocytes th ro u g h p aracrine/autocrine signaling in the tu m o r m icroenvironm ent. C an cer Lett. 2016; 376(2):318-327.
84. E k strö m E J, B e rgenfelz C, v o n B ü lo w V, S erifler F, C arlem alm E et al. W N T 5A induces release o f exosom es contain in g pro-angiogenic and im m unosuppressive facto rs fro m m alig n an t m elanom a cells. M ol Cancer.
2014; 13:88.
85. H o o d JL, San R S, W ickline SA. E xosom es released by m elanom a cells prepare sentinel ly m p h nodes fo r tu m o r m etastasis. C ancer Res. 2011; 71(11):3792-3801.
86. G y ukity-S ebestyén E, H arm ati M , D o b ra G, N ém e th IB, M ihaly J et al. M elanom a-derived exosom es induce pd-1 overex p ressio n and tu m o r p ro g re ssio n v ia m esenchym al stem cell oncogenic reprogram m ing. F ront
Im m unol. 2019; 10:2459.
87. W ieckow ski E U , V isus C, S zajnik M , Szczepanski M J, S torkus W J et al. T um or-derived m icrovesicles p rom ote regulatory T cell expansion and induce apoptosis in tu m or-reactive activated C D 8+ T lym phocytes.
J Im m unol. 2009; 183(6):3720-3730.
88. B la n d CL, B y rn e-H o ffm an CN, F ernandez A, R e llick SL, D en g W et al. E xosom es derived from B16F0 m elan o m a cells alter the transcriptom e o f cytotoxic T cells th a t im pacts m itochondrial respiration. F EB S J.
2018; 285(6):1033-1050.
89. L u n av at TR , C heng L, E in arsd o ttir BO , O lo fsso n B agge R, V eppil M u ralid h aran S et al. B R A FV 600 inhib itio n alters th e m icro R N A cargo in the v esicu lar secretom e o f m alignant m elanom a cells. P roc N atl A cad Sci U S A. 2017; 114(29):E 5930-E 5939.
90. A ndrade L N S, O take A H , C ardim SGB, da S ilva FI, Ikom a Sakam oto M M et al. E xtracellular vesicles shedding prom otes m elanom a gro w th in response to chem otherapy. Sci Rep. 2019; 9(1):14482.
91. M uhsin-S harafaldine M R , S aunderson SC, D u n n AC, F aed JM , K leffm an n T et al. Procoagulant and im m unogenic p roperties o f m elanom a exosom es, m icrovesicles and apoptotic vesicles. O ncotarget. 2016;
7(35):56279-56294.
92. L auc G, K ristić J, Z oldos V. G ly ca n s-th e th ird revolution in evolution. Front. G enet. 2014; 5:145-152.
93. O htsubo K , M a rth JD. G lycosylation in cellu lar m echanism s o f h ealth and disease. Cell. 2006; 126:855-867.
94. F ran tz C, S tew art K M , W e av e r V M . T he ex tracellular m atrix at a glance. J C ell Sci. 2010; 123:4195-4200.
95. L ia n g Y , E n g W S, C olquhoun D R, D in g lasan R R , G raham D R et al. C om plex N -linked glycans serve as a d eterm inant fo r exosom e/m icrovesicle cargo recruitm ent. J B iol Chem . 2014; 289(47):32526-32537.
96. G om es J, G om es-A lves P, C arvalho SB, P eixoto C, A lves P M et al. E xtracellular V esicles from O varian C arcinom a C ells D isplay Specific G lycosignatures. B iom olecules. 2015; 5(3): 1741-1761.
97. T h o m p so n CA, P uru sh o th am an A, R am ani V C, V lodavsky I, S anderson RD . H eparanase regulates secretion, com position, an d fu n ctio n o f tu m o r cell-derived exosom es. J B iol Chem . 2013; 288(14): 10093-10099.
98. B arrès C, B lanc L, B ette-B obillo P, A ndré S, M a m o u n R et al. G alectin-5 is bound onto the surface o f rat reticulocyte exosom es an d m odulates v esicle uptake b y m acrophages. B lood. 2010; 115(3):696-705.
99. W illiam s C, P azos R , R oyo F, G onzalez E, R o u ra-F erre r M et al. A ssessing the role o f surface glycans o f ex tracellu lar v esicles o n ce llu lar uptake. Sci Rep. 2019; 9(1):11920.
100. R oyo F, C ossio U , R uiz de A ngulo A, L lop J, F alco n -P erez JM . M odificatio n o f th e g lycosylation o f ex tracellu lar v esicles alters th e ir b io d istrib u tio n in m ice. N anoscale. 2019; 11(4): 1531-1537.
101. H u n g M E, L eo n a rd JN. S tabilization o f exo so m e-targ etin g p eptides v ia engineered glycosylation. J B iol Chem . 2015; 290(13):8166-8172.
102. C h ristianson H C , Svensson KJ, v a n K u ppevelt TH, L i JP, B e ltin g M . C ancer cell exosom es dep en d o n cell- surface h eparan sulfate p roteoglycans fo r th e ir internalization an d fu nctional activity. P roc N atl A cad Sci U S A. 2013; 110(43):17380-17385.
103. F ra n ze n CA, Sim m s PE, V an H uis AF, F o re m an KE, K uo P C et al. C haracterization o f uptake and in tern alizatio n o f exosom es b y b la d d er can cer cells. B io m ed R es Int. 2014; 2014:619829.
104. C h en L, B rig sto ck D R. Integrins and h eparan sulfate proteoglycans o n hepatic stellate cells (H SC ) are novel receptors fo r H S C -d eriv ed exosom es. F E B S Lett. 2016; 590(23):4263-4274.
105. S taubach S, Schadew aldt P, W endel U , N ohroudi K, H an isch FG. D ifferential glycom ics o f epithelial
m em brane glycoproteins fro m urinary exovesicles reveals shifts to w ard com plex-type N -gly co sy latio n in classical galactosem ia. J P roteom e Res. 2012; 11(2):906-916.
106. B a tista B S, E n g W S, P ilobello K T, H endricks-M unoz K D , M ah al LK. Id entification o f a conserved g lycan signature fo r m icrovesicles. J P roteom e R es. 2011; 10(10):4624-4633.
107. E screvente C, G ram m el N , K andzia S, Z e ise r J, T ranfield E M e t al. Sialoglycoproteins and N -glycans from secreted exosom es o f ovarian carcinom a cells. P L oS One. 2013; 8(10):e78631.
108. M e n ck K , S ch arf C, B leck m an n A, D y ck L, R o st U et al. T um or-derived m icrovesicles m ediate hum an breast ca n ce r inv asio n th ro u g h differentially g lycosylated E M M P R IN . J M o l C ell Biol. 2015; 7(2): 143-153.
109. R a n ja n A, K alraiya RD . a2 ,6 sialylation associated w ith increased b eta 1,6-branched N -oligosaccharides influences ce llu lar ad h e sio n an d invasion. J B iosci. 2013; 38(5):867-876.
110. P rzybyło M , Jan ik M , H oja-Ł ukow icz D. B itte r sw eetness o f m alig n an t m elanom a: deciphering the role o f cell surface glyco sy latio n in tu m o u r p ro g ressio n an d m etastasis. IntechO pen. 2016; 63-87.
111. T an g L, C hen X, Z h an g X , G uo Y , Su J et a l . N -G lycosylation in progression o f skin cancer. M ed Oncol.
2019; 36(6):50.
112. H oja-Ł ukow icz D, P rzybyło M , D u d a M , P ocheć E, B u b k a M . O n the trail o f the g ly c an codes stored in can cer-related cell ad h e sio n proteins. B io ch im B iophys A cta G en Subj. 2017; 1861(1 P t A ):3237-3257.
113. T aniguchi N , M iyoshi E, K o JH , Ik ed a Y, Ih ara Y. Im plication o f N -acetylglucosam inyltransferases III and V in cancer: gene regu latio n and signaling m echanism . B io ch im B iophys Acta. 1999; 1455(2-3):287-300.
114. M iw a H E, Song Y , A lvarez R, C um m ings RD , Stanley P. The b isectin g G lcN A c in cell g ro w th control and tu m o r progression. G lycoconj J. 2012; 29(8-9):609-618.
115. P rzybyło M , M artu szew sk a D , P ocheć E, H oja-Ł ukow icz D , L ity ń sk a A. Id entification o f pro tein s bearin g beta1 -6 b ran c h ed N -glycans in h um an m elanom a cell lines from d ifferent p ro g ressio n stages by tan d em m ass spectrom etry analysis. B iochim B iophys Acta. 2007; 1770(9):1427-1435.
116. P rzybyło M , P ocheć E, L ink-L enczow ski P, L ity ń sk a A. B eta1-6 b ran ch in g o f cell surface glycoproteins m ay contribute to uveal m elanom a p ro g ressio n b y up-reg u latin g cell m otility. M ol Vis. 2008; 14:625-636.
117. P ocheć E, R yd lew sk a M , P rzybyło M , L ity ń sk a A. D iverse ex p ressio n o f N -acetylglucosam inyltransferase V an d com plex-type ß1,6-branched N -glycans in u v eal an d cutaneous m elanom a cells. A cta B io ch im Pol.
2015; 62(2):323-328.
118. H an d e rso n T, B e rg e r A, H arigopol M , R im m D, N ishigori C et al. M elanophages reside in hyperm elanotic, aberrantly g lycosylated tu m o r areas an d predict im proved outcom e in prim ary cutaneous m alignant m elanom a. J C lin P athol. 2007; 34:679-686.
119. Y o sh im u ra M , N ish ik aw a A, Ihara Y , T aniguchi S, T aniguchi N. S uppression o f lu n g m etastasis o f B 16 m ouse m elanom a b y N -acetylglucosam inyltransferase III gene transfection. P roc N atl A cad Sci U S A. 1995;
92(19):8754-8748.
120. H u m p h ries M J, M atsum oto K , W hite SL, O ld en K. O ligosaccharide m odification by sw ainsonine treatm ent inhibits pulm onary co lo n izatio n by B 16F 10 m urine m elanom a cells. P roc N atl A cad Sci U S A. 1986;
S3:1752-1756.
121. D en n is JW , K o c h K, Y o u sefi S, V ander E. G ro w th inhibition o f h um an m elan o m a tu m o r xenografts in athym ic nude m ice b y sw ainsonine. C ancer R es. 1990; 50:1867-1872.
122. C iołczyk-W ierzbicka D, B o d z io c h M , G il D, Z m udzińska D , D em bińska-K ieć A et al. E xpression o f
fucosyltransferases contributes to m elan o m a invasive phenotype. M ed Chem . 2007; 3(5):418-424.
123. A graw al P, F o ntanals-C irera B, Sokolova E, Jacob S, V aiana CA, et al. A System s B iology A pproach Identifies F U T 8 as a D riv er o f M elanom a M etastasis. C ancer Cell. 2017; 31(6):804-819.e7.
124. S chultz M J, S w indall AF, B ellis SL. R egu latio n o f the m etastatic cell phenotype b y sialylated glycans.
C an cer M etastasis Rev. 2012; 31(3-4):501-518.
125. M onzavi-K arbassi B , P ashov A, K ieber-E m m ons T. T um or-A ssociated G lycans and Im m une Surveillance.
V accines (Basel). 2013; 1(2):174-203.
V accines (Basel). 2013; 1(2):174-203.